Development
AbCellera Biologics Inc.
ABCL
$4.59
$0.092.00%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.20% | -9.49% | -22.16% | 1.33% | 22.62% |
| Total Receivables | -37.74% | -64.66% | -13.48% | -70.22% | -40.86% |
| Inventory | -27.74% | -- | -- | -- | -8.37% |
| Prepaid Expenses | 130.70% | -- | -- | -- | 71.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -11.84% | -4.84% | -53.64% | 0.00% |
| Total Current Assets | -14.97% | -12.06% | -18.64% | -19.90% | 10.29% |
|
|
|||||
| Total Current Assets | -14.97% | -12.06% | -18.64% | -19.90% | 10.29% |
| Net Property, Plant & Equipment | 32.42% | 38.19% | 74.05% | 91.06% | 94.65% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -8.42% | -12.96% | -11.48% | -11.62% | -11.38% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.62% | -41.17% | 8.71% | -11.28% | 73.58% |
| Total Assets | -3.43% | -2.59% | -3.55% | -5.93% | 16.86% |
|
|
|||||
| Total Accounts Payable | 72.03% | 87.06% | 103.87% | 69.72% | -0.64% |
| Total Accrued Expenses | -58.14% | -59.92% | -87.32% | -90.56% | -2.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.30% | 23.36% | 47.97% | 49.69% | 52.88% |
| Total Finance Division Other Current Liabilities | 6.15% | 13.32% | -44.08% | -58.43% | -4.57% |
| Total Other Current Liabilities | 6.15% | 13.32% | -44.08% | -58.43% | -4.57% |
| Total Current Liabilities | 0.59% | 3.95% | -46.23% | -58.02% | -1.95% |
|
|
|||||
| Total Current Liabilities | 0.59% | 3.95% | -46.23% | -58.02% | -1.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.11% | 5.02% | 138.34% | 112.52% | 110.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.21% | 15.57% | 14.43% | -9.22% | -17.03% |
| Total Liabilities | 9.15% | 8.99% | -10.13% | -24.78% | 5.05% |
|
|
|||||
| Common Stock & APIC | 8.13% | 7.86% | 7.45% | 7.00% | 6.69% |
| Retained Earnings | -34.35% | -28.32% | -17.21% | -11.50% | 59.22% |
| Treasury Stock & Other | -23.65% | -103.63% | -429.69% | -356.80% | -596.79% |
| Total Common Equity | -6.56% | -5.39% | -1.49% | 0.08% | 20.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.56% | -5.39% | -1.49% | 0.08% | 20.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.56% | -5.39% | -1.49% | 0.08% | 20.23% |
|
|
|||||